5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells

Prostaglandins and Other Lipid Mediators

Volumn 84, Issue 3-4, 2007, Pages 108-115

  Lötzer, Katharina ^a   Jahn, Steffen ^a   Kramer, Cornelia ^a   Hildner, Markus ^a   Nüsing, Rolf ^b   Funk, Colin D ^c   Habenicht, Andreas J R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Cyclooxygenase 2; Cysteinyl leukotriene receptor; Endothelial cells; Leukotriene D4; Prostacyclin

Indexed keywords

6 KETO PROSTAGLANDIN F1 ALPHA; ARACHIDONATE 5 LIPOXYGENASE; CALCIUM; CYCLOOXYGENASE 2; CYCLOSPORIN A; CYSTEINYL LEUKOTRIENE RECEPTOR 2; ICOSANOID; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NUCLEAR FACTOR; PROSTACYCLIN; PROSTAGLANDIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART PROTECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION;

ARACHIDONATE 5-LIPOXYGENASE; CALCIUM SIGNALING; CYCLOOXYGENASE 2; CYCLOSPORINE; ENDOTHELIAL CELLS; EPOPROSTENOL; HUMANS; LEUKOTRIENE D4; MEMBRANE PROTEINS; RECEPTOR CROSS-TALK; RECEPTORS, LEUKOTRIENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS; UP-REGULATION;

EID: 35648950401     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2007.04.005     Document Type: Article

References (27)

1. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
2. Cheng Y., Austin S.C., Rocca B., et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296 (2002) 539-541
3. Egan K.M., Lawson J.A., Fries S., et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 (2004) 1954-1957
4. Fitzgerald G.A. Coxibs and cardiovascular disease. N Engl J Med 351 (2004) 1709-1711
5. De Caterina R., Mazzone A., Giannessi D., et al. Leukotriene B4 production in human atherosclerotic plaques. Biomed Biochim Acta 47 (1988) S182-S185
6. Brezinski D.A., Nesto R.W., and Serhan C.N. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86 (1992) 56-63
7. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100 (2003) 1238-1243
8. 2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 276 (2001) 47489-47495
9. Uzonyi B., Lotzer K., Jahn S., et al. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc Natl Acad Sci USA 103 (2006) 6326-6331
10. Lotzer K., Spanbroek R., Hildner M., et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 23 (2003) e32-e36
11. Klein T., Reutter F., Schweer H., Seyberth H.W., and Nusing R.M. Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. J Pharmacol Exp Ther 282 (1997) 1658-1665
12. Ciana P., Fumagalli M., Trincavelli M.L., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25 (2006) 4615-4627
13. Allen S.P., and Yacoub M.H. Role of leukotrienes in coronary artery surgery. Curr Opin Cardiol 10 (1995) 605-613
14. Fiore S., and Serhan C.N. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 172 (1990) 1451-1457
15. Maclouf J.A., and Murphy R.C. Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4. J Biol Chem 263 (1988) 174-181
16. Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
17. Claria J., and Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92 (1995) 9475-9479
18. Fiorucci S., Distrutti E., Mencarelli A., et al. Evidence that 5-lipoxygenase and acetylated cyclooxygenase-2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol 139 (2003) 1351-1359
19. Massoumi R., Nielsen C.K., Azemovic D., and Sjolander A. Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and up-regulation of alpha2beta1-integrin. Exp Cell Res 289 (2003) 342-351
20. Ohd J.F., Wikstrom K., and Sjolander A. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119 (2000) 1007-1018
21. Rossi A., Acquaviva A.M., Iuliano F., Di Paola R., Cuzzocrea S., and Sautebin L. Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-{gamma}. J Leukoc Biol 78 (2005) 985-991
22. Wikstrom K., Ohd J.F., and Sjolander A. Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2. Biochem Biophys Res Commun 302 (2003) 330-335
23. 2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) e37-e41
24. Eligini S., Stella Barbieri S., Cavalca V., et al. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovasc Res 65 (2005) 683-693
25. Hernandez G.L., Volpert O.V., Iniguez M.A., et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase-2. J Exp Med 193 (2001) 607-620
26. Loots G.G., Ovcharenko I., Pachter L., Dubchak I., and Rubin E.M. rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res 12 (2002) 832-839
27. Lotzer K., Funk C.D., and Habenicht A.J. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 1736 (2005) 30-37